Suchergebnisse - "*Antirheumatic Agents"

PubPharm (271)

1

Comment on : Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis

enthalten in: Rheumatology (Oxford, England) | 2024

von Misra, D.

2

Influence of Gender on the Persistence of Different Tumor Necrosis Factor Inhibitor Treatments in Patients With Psoriatic Arthritis

enthalten in: The Journal of rheumatology | 2024

von García-Porrúa, C. | Iñiguez-Ubiaga, C. | Pinto-Tasende, J.

3

Patient perceptions on switching from reference product adalimumab to biosimilar adalimumab-atto

enthalten in: Clinical rheumatology | 2024

von Pham, C. | Niu, F. | Hui, R. | +2

4

'Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients'-response to Yu et al

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Mastorino, L. | Ortoncelli, M. | Dapavo, P. | +2

5

Regarding Mastorino et al.'s 'Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients'

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2023

von Yu, S. | Wei, J.

6

Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC

enthalten in: Rheumatology (Oxford, England) | 2022

von Coates, L. | Garrood, T. | Gullick, N. | +8

7

Remission of psoriatic arthritis 24 h after adalimumab therapy

enthalten in: Dermatologic therapy | 2022

von Song, S. | Wan, L. | Xia, P. | +1

8

Adalimumab biosimilar in a pediatric patient : Clinical and in vivo reflectance confocal microscopy evaluation

enthalten in: Dermatologic therapy | 2022

von Megna, M. | Villani, A. | Potestio, L. | +3

9

Recalcitrant and persistent adalimumab-induced paradoxical psoriasiform skin reaction in a rheumatoid arthritis patient successfully treated with upadacitinib

enthalten in: Dermatologic therapy | 2022

von Zabotti, A. | Giovannini, I. | De Vita, S. | +2

10

Cutaneous tuberculosis induced by adalimumab

enthalten in: Dermatologic therapy | 2022

von Gürel, G. | Özdemir, �. | Durusu, �.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[28]